A targeting mutation of tyrosine 1062 in Ret causes a marked decrease of enteric neurons and renal hypoplasia

Molecular and Cellular Biology

Volumn 24, Issue 18, 2004, Pages 8026-8036

  Jijiwa, Mayumi ^a   Fukuda, Toshifumi ^a,b   Kawai, Kumi ^a   Nakamura, Akari ^a   Kurokawa, Kei ^a   Murakumo, Yoshiki ^a   Ichihara, Masatoshi ^a   Takahashi, Masahide ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTYROSINE; PROTEIN RET; TYROSINE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HIRSCHSPRUNG DISEASE; HISTOLOGY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE INNERVATION; KIDNEY HYPOPLASIA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; ORGANOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; TRANSGENIC MOUSE;

ABNORMALITIES, MULTIPLE; ANIMALS; BASE SEQUENCE; DNA; ENTERIC NERVOUS SYSTEM; KIDNEY; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MUTAGENESIS, SITE-DIRECTED; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER; TYROSINE;

ANIMALIA; MUS MUSCULUS;

EID: 4444324911     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.18.8026-8036.2004     Document Type: Article

References (66)

1. Airaksinen, M. S., and M. Saarma. 2002. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3:383-394.
2. Alberti, L., M. G. Borrello, S. Ghizzoni, F. Torriti, M. G. Rizzetti, and M. A. Pierotti. 1998. Grb2 binding to the different isoforms of Ret tyrosine kinase. Oncogene 17:1079-1087.
3. Andreozzi, F., R. M. Melillo, F. Carlomagno, F. Oriente, C. Miele, F. Fiory, S. Santopietro, M. D. Castellone, F. Beguinot, M. Santoro, and P. Formisano. 2003. Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase. Oncogene 22:2942-2949.
4. Arighi, E., L. Alberti, F. Torriti, S. Ghizzoni, M. G. Rizzetti, G. Pelicci, B. Pasini, I. Bongarzone, C. Piutti, M. A. Pierotti, and M. G. Borrello. 1997. Identification of Shc docking site on Ret tyrosine kinase. Oncogene 14:773-782.
5. Asai, N., H. Murakami, T. Iwashita, and M. Takahashi. 1996. A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins. J. Biol. Chem. 271:17644-17649.
6. Barlow, A., E. de Graaff, and V. Pachnis. 2003. Enteric nervous system progenitors are coordinately controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase RET. Neuron 40:905-916.
7. Besset, V., R. P. Scott, and C. F. Ibanez. 2000. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J. Biol. Chem. 275:39159-39166.
8. Bordeaux, M. C., C. Forcet, L. Granger, V. Corset, C. Bidaud, M. Billaud, D. E. Bredesen, P. Edery, and P. Mehlen. 2000. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J. 19:4056-4063.
9. Borrello, M. G., L. Alberti, E. Arighi, I. Bongarzone, C. Battistini, A. Bardelli, B. Pasini, C. Piutti, M. G. Rizzetti, P. Mondellini, M. T. Radice, and M. A. Pierotti. 1996. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cγ. Mol. Cell. Biol. 16:2151-2163.
10. Cacalano, G., I. Farinas, L. C. Wang, K. Hagler, A. Forgie, M. Moore, M. Armanini, H. Phillips, A. M. Ryan, L. F. Reichardt, M. Hynes, A. Davies, and A. Rosenthal. 1998. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21:53-62.
11. Carlomagno, F., G. De Vita, M. T. Berlingieri, V. de Franciscis, R. M. Melillo, V. Colantuoni, M. H. Kraus, P. P. Di Fiore, A. Fusco, and M. Santoro. 1996. Molecular heterogeneity of RET loss of function in Hirschsprung's disease. EMBO J. 15:2717-2725.
12. Cosma, M. P., M. Cardone, F. Carlomagno, and V. Colantuoni. 1998. Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism. Mol. Cell. Biol. 18:3321-3329.
13. de Graaff, E., S. Srinivas, C. Kilkenny, V. D'Agati, B. S. Mankoo, F. Costantini, and V. Pachnis. 2001. Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis. Genes Dev. 15:2433-2444.
14. De Vita, G., R. M. Melillo, F. Carlomagno, R. Visconti, M. D. Castellone, A. Bellacosa, M. Billaud, A. Fusco, P. N. Tsichlis, and M. Santoro. 2000. Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival. Cancer Res. 60:3727-3731.
15. Durick, K., R. Y. Wu, G. N. Gill, and S. S. Taylor. 1996. Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain. J. Biol. Chem. 271:12691-12694.
16. Edery, P., S. Lyonnet, L. M. Mulligan, A. Pelet, E. Dow, L. Abel, S. Holder, C. Nihoul-Fekete, B. A. Ponder, and A. Munnich. 1994. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367:378-380.
17. Encinas, M., M. G. Tansey, B. A. Tsui-Pierchala, J. X. Comella, J. Milbrandt, and E. M. Johnson, Jr. 2001. c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway. J. Neurosci. 21:1464-1472.
18. Focke, P. J., A. R. Swetlik, J. L. Schilz, and M. L. Epstein. 2003. GDNF and insulin cooperate to enhance the proliferation and differentiation of enteric crest-derived cells. J. Neurobiol. 55:151-164.
19. Fukuda, T., K. Kiuchi, and M. Takahashi. 2002. Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase. J. Biol. Chem. 277:19114-19121.
20. Geneste, O., C. Bidaud, G. De Vita, R. M. Hofstra, S. Tartare-Deckert, C. H. Buys, G. M. Lenoir, M. Santoro, and M. Billaud. 1999. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site. Hum. Mol. Genet. 8:1989-1999.
21. Gianino, S., J. R. Grider, J. Cresswell, H. Enomoto, and R. O. Heuckeroth. 2003. GDNF availability determines enteric neuron number by controlling precursor proliferation. Development 130:2187-2198.
22. Grimm, J., M. Sachs, S. Britsch, S. Di Cesare, T. Schwarz-Romond, K. Alitalo, and W. Birchmeier. 2001. Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J. Cell Biol. 154:345-354.
23. Hayashi, H., M. Ichihara, T. Iwashita, H. Murakami, Y. Shimono, K. Kawai, K. Kurokawa, Y. Murakumo, T. Imai, H. Funahashi, A. Nakao, and M. Takahashi. 2000. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene 19. 4469-4475.
24. Hayashi, Y., T. Iwashita, H. Murakamai, Y. Kato, K. Kawai, K. Kurokawa, I. Tohnai, M. Ueda, and M. Takahashi. 2001. Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation. Biochem. Biophys. Res. Commun. 281:682-689.
25. Hearn, C. J., M. Murphy, and D. Newgreen. 1998. GDNF and ET-3 differentially modulate the numbers of avian enteric neural crest cells and enteric neurons in vitro. Dev. Biol. 197:93-105.
26. Heuckeroth, R. O., H. Enomoto, J. R. Grider, J. P. Golden, J. A. Hanke, A. Jackman, D. C. Molliver, M. E. Bardgett, W. D. Snider, E. M. Johnson, Jr., and J. Milbrandt. 1999. Gene targeting reveals a critical role for neurturin in the development and maintenance of enteric, sensory, and parasympathetic neurons. Neuron 22:253-263.
27. Heuckeroth, R. O., P. A. Lampe, E. M. Johnson, and J. Milbrandt. 1998. Neurturin and GDNF promote proliferation and survival of enteric neuron and glial progenitors in vitro. Dev. Biol. 200:116-129.
28. Ishiguro, Y., T. Iwashita, H. Murakami, N. Asai, K. Iida, H. Goto, T. Hayakawa, and M. Takahashi. 1999. The role of amino acids surrounding tyrosine 1062 in ret in specific binding of the shc phosphotyrosine-binding domain. Endocrinology 140:3992-3998.
29. Ito, S., T. Iwashita, N. Asai, H. Murakami, Y. Iwata, G. Sobue, and M. Takahashi. 1997. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype. Cancer Res. 57:2870-2872.
30. Iwashita, T., G. M. Kruger, R. Pardal, M. J. Kiel, and S. J. Morrison. 2003. Hirschsprung disease is linked to defects in neural crest stem cell function. Science 301(Suppl. 32):972-976.
31. Iwashita, T., K. Kurokawa, S. Qiao, H. Murakami, N. Asai, K. Kawai, M. Hashimoto, T. Watanabe, M. Ichihara, and M. Takahashi. 2001. Functional analysis of RET with Hirschsprung mutations affecting its kinase domain. Gastroenterology 121(Suppl. 30):24-33.
32. Iwashita, T., H. Murakami, N. Asai, and M. Takahashi. 1996. Mechanism of ret dysfunction by Hirschsprung mutations affecting its extracellular domain. Hum. Mol. Genet. 5:1577-1580.
33. Kenny, S. E., R. M. Hofstra, C. H. Buys, C. R. Vaillant, D. A. Lloyd, and D. H. Edgar. 2000. Reduced endothelin-3 expression in sporadic Hirschsprung disease. Br. J. Surg. 87:580-585.
34. Kissel, H., I. Timokhina, M. P. Hardy, G. Rothschild, Y. Tajima, V. Soares, M. Angeles, S. R. Whitlow, K. Manova, and P. Besmer. 2000. Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses. EMBO J. 19:1312-1326.
35. Kurokawa, K., T. Iwashita, H. Murakami, H. Hayashi, K. Kawai, and M. Takahashi. 2001. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction. Oncogene 20:1929-1938.
36. Lee, K. Y., E. T. Samy, M. H. Sham, P. K. Tam, and V. C. Lui. 2003. 3′ splicing variants of ret receptor tyrosine kinase are differentially expressed in mouse embryos and in adult mice. Biochim. Biophys. Acta 1627:26-38.
37. Leibl, M. A., T. Ota, M. N. Woodward, S. E. Kenny, D. A. Lloyd, C. R. Vaillant, and D. H. Edgar. 1999. Expression of endothelin 3 by mesenchymal cells of embryonic mouse caecum. Gut 44:246-252.
38. Lorenzo, M. J., G. D. Gish, C. Houghton, T. J. Stonehouse, T. Pawson, B. A. Ponder, and D. P. Smith. 1997. RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2. Oncogene 14:763-771.
39. Maina, F., G. Pante, F. Helmbacher, R. Andres, A. Porthin, A. M. Davies, C. Ponzetto, and R. Klein. 2001. Coupling Met to specific pathways results in distinct developmental outcomes. Mol. Cell 7:1293-1306.
40. Manie, S., M. Santoro, A. Fusco, and M. Billaud. 2001. The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet. 17:580-589.
41. McCallion, A. S., and A. Chakravarti. 2001. EDNRB/EDN3 and Hirschsprung disease type II. Pigment Cell Res. 14(Suppl. 43):161-169.
42. Melillo, R. M., F. Carlomagno, G. De Vita, P. Formisano, G. Vecchio, A. Fusco, M. Billaud, and M. Santoro. 2001. The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competiton between Shc and IRS-1 for the binding to Ret. Oncogene 20:209-218.
43. Melillo, R. M., M. Santoro, S. H. Ong, M. Billaud, A. Fusco, Y. R. Hadari, J. Schlessinger, and I. Lax. 2001. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol. Cell. Biol. 21:4177-4187.
44. Moore, M. W., R. D. Klein, I. Farinas, H. Sauer, M. Armanini, H. Phillips, L. F. Reichardt, A. M. Ryan, K. Carver-Moore, and A. Rosenthal. 1996. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382:76-79.
45. Murakami, H., Y. Yamamura, Y. Shimono, K. Kawai, K. Kurokawa, and M. Takahashi. 2002. Role of Dok1 in cell signaling mediated by RET tyrosine kinase. J. Biol. Chem. 277:32781-33290.
46. Natarajan, D., C. Marcos-Gutierrez, V. Pachnis, and E. de Graaff. 2002. Requirement of signalling by receptor tyrosine kinase RET for the directed migration of enteric nervous system progenitor cells during mammalian embryogenesis. Development 129:5151-5160.
47. Nozaki, C., N. Asai, H. Murakami, T. Iwashita, Y. Iwata, K. Horibe, R. D. Klein, A. Rosenthal, and M. Takahashi. 1998. Calcium-dependent Ret activation by GDNF and neurturin. Oncogene 16:293-299.
48. Ohiwa, M., H. Murakami, T. Iwashita, N. Asai, Y. Iwata, T. Imai, H. Funahashi, H. Takagi, and M. Takahashi. 1997. Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations. Biochem. Biophys. Res. Commun. 237:747-751.
49. Pandey, A., H. Duan, P. P. Di Fiore, and V. M. Dixit. 1995. The Ret receptor protein tyrosine kinase associates with the SH2-containing adapter protein Grb10. J. Biol. Chem. 270:21461-21463.
50. Pasini, B., M. G. Borrello, A. Greco, I. Bongarzone, Y. Luo, P. Mondellini, L. Alberti, C. Miranda, E. Arighi, R. Bocciardi, et al. 1995. Loss of function effect of RET mutations causing Hirschsprung disease. Nat. Genet. 10:35-40.
51. Pelet, A., O. Geneste, P. Edery, A. Pasini, S. Chappuis, T. Atti, A. Munnich, G. Lenoir, S. Lyonnet, and M. Billaud. 1998. Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease. J. Clin. Investig. 101:1415-1423.
52. Pichel, J. G., L. Shen, H. Z. Sheng, A. C. Granholm, J. Drago, A. Grinberg, E. J. Lee, S. P. Huang, M. Saarma, B. J. Hoffer, H. Sariola, and H. Westphal. 1996. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382:73-76.
53. Romeo, G., P. Ronchetto, Y. Luo, V. Barone, M. Seri, I. Ceccherini, B. Pasini, R. Bocciardi, M. Lerone, H. Kaariainen, et al. 1994. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367:377-378.
54. Sanchez, M. P., I. Silos-Santiago, J. Frisen, B. He, S. A. Lira, and M. Barbacid. 1996. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382:70-73.
55. Schuchardt, A., V. D'Agati, L. Larsson-Blomberg, F. Costantini, and V. Pachnis. 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367:380-383.
56. Schuchardt, A., V. D'Agati, V. Pachnis, and F. Costantini. 1996. Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development. Development 122:1919-1929.
57. Segouffin-Cariou, C., and M. Billaud. 2000. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway. J. Biol. Chem. 275:3568-3576.
58. Sidebotham, E. L., M. N. Woodward, S. E. Kenny, D. A. Lloyd, C. R. Vaillant, and D. H. Edgar. 2002. Localization and endothelin-3 dependence of stem cells of the enteric nervous system in the embryonic colon. J. Pediatr. Surg. 37:145-150.
59. Tahira, T., Y. Ishizaka, F. Itoh, T. Sugimura, and M. Nagao. 1990. Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene 5:97-102.
60. Takahashi, M. 2001. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev. 12:361-373.
61. Tang, M. J., Y. Cai, S. J. Tsai, Y. K. Wang, and G. R. Dressler. 2002. Ureteric bud outgrowth in response to RET activation is mediated by phosphatidylinositol 3-kinase. Dev. Biol. 243:128-136.
62. Taraviras, S., C. V. Marcos-Gutierrez, P. Durbec, H. Jani, M. Grigoriou, M. Sukumaran, L. C. Wang, M. Hynes, G. Raisman, and V. Pachnis. 1999. Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development 126:2785-2797.
63. Woodward, M. N., E. L. Sidebotham, M. G. Connell, S. E. Kenny, C. R. Vaillant, D. A. Lloyd, and D. H. Edgar. 2003. Analysis of the effects of endothelin-3 on the development of neural crest cells in the embryonic mouse gut. J. Pediatr. Surg. 38:1322-1328.
64. Worley, D. S., J. M. Pisano, E. D. Choi, L. Walus, C. A. Hession, R. L. Cate, M. Sanicola, and S. J. Birren. 2000. Developmental regulation of GDNF response and receptor expression in the enteric nervous system. Development 127:4383-4393.
65. Young, H. M., C. J. Hearn, P. G. Farlie, A. J. Canty, P. Q. Thomas, and D. F. Newgreen. 2001. GDNF is a chemoattractant for enteric neural cells. Dev. Biol. 229:503-516.
66. Young, H. M., and D. Newgreen. 2001. Enteric neural crest-derived cells: origin, identification, migration, and differentiation. Anat. Rec. 262:1-15.